Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Phase 1b, Multi-cohort Clinical Trial Assessing Safety and Feasibility of Exercise and Spermidine Administered in Conjunction With Lamivudine (RTi) or Rapamycin (mTORi) to Assess Impact on Dynamic Changes of Inflammation and Aging

Authors not listed

Icahn School of Medicine at Mount Sinai · 2025

Deregulated nutrient-sensing Chronic inflammation Rapamycin / mTOR inhibition Spermidine Exercise Human Randomized controlled trial

＋ Sign in to save

Abstract

This is a study assessing the feasibility of performing an anti-aging intervention which is a combination of an exercise regimen, spermidine supplementation, and either mTOR-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin or lamivudine.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-31 MST

Cite this

APA

Anonymous. (2025). A Phase 1b, Multi-cohort Clinical Trial Assessing Safety and Feasibility of Exercise and Spermidine Administered in Conjunction With Lamivudine (RTi) or Rapamycin (mTORi) to Assess Impact on Dynamic Changes of Inflammation and Aging. <em>Icahn School of Medicine at Mount Sinai</em>. https://clinicaltrials.gov/study/NCT07058974

Vancouver

Anonymous. A Phase 1b, Multi-cohort Clinical Trial Assessing Safety and Feasibility of Exercise and Spermidine Administered in Conjunction With Lamivudine (RTi) or Rapamycin (mTORi) to Assess Impact on Dynamic Changes of Inflammation and Aging. Icahn School of Medicine at Mount Sinai. 2025.

BibTeX

@misc{anon2025APhase, title = {A Phase 1b, Multi-cohort Clinical Trial Assessing Safety and Feasibility of Exercise and Spermidine Administered in Conjunction With Lamivudine (RTi) or Rapamycin (mTORi) to Assess Impact on Dynamic Changes of Inflammation and Aging}, author = {Anonymous}, journal = {Icahn School of Medicine at Mount Sinai}, year = {2025}, }